Atlas Trials

Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment

Clinical trial NCT00802568 · COMPLETED

Trial details

NCT number
NCT00802568
Sponsor
Institut Paoli-Calmettes
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell Neoplasm
Start date
2007-04-01
Primary completion
2011-05-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.